Earnings Review · 19 November 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-11-19 the shares closed at $310.02, -1.0% against the prior close of $313.24 (opening -0.6% from the prior close). Across the last 25 reports the shares have moved an average of +0.2% over the five sessions after the print, so the -1.0% on the day sits behind that average.
Did the flow confirm the move?
Underlying money flow is neutral (21-day Chaikin Money Flow +0.01, five-day price change -5.8%, as of 2026-11-17, desk flow model): no strong accumulation or distribution signature.
Give the business its due
The business itself is genuinely strong: revenue growing about 14%,
net margins near 21%, a strong competitive moat, backed by a 24%
return on equity.
Levels that matter
At $310.02 the shares sit 55% below the 52-week high of $682.27 and 23% above the low of $252.84 (13% of the way up the range). The 50-day average is $317.98, above the price. The 200-day average is $348.85, above the price.
The valuation lens
Our fair-value work puts the shares about 38% below what the business is worth: value on offer. Fair value lands near $500 against a $310.02 share price, a margin of safety of about 38%. The trailing multiple sits around 21 times earnings, which only makes sense if the growth holds.
The
ethical lens, our differentiator
Screens compliant (both standards agree). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.